Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3500943011 | Hydroxyapatite 830 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4042410014 | Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4042411013 | Durapatite 830 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 56969501000001116 | Hydroxyapatite 830mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing durapatite (medicinal product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Mineral supplement | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Nutrient supplementation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Genitourinary agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Nutritional supplement | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 830 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing durapatite in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only calcium phosphate in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance | Hydroxyapatite | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Hydroxyapatite | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing only durapatite in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Hydroxyapatite | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Hydroxyapatite | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has specific active ingredient | Hydroxyapatite | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydroxyapatite 830mg tablet - product | Is a | False | Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Ossopan 800 tablets (Sanofi-Synthelabo Ltd) | Is a | True | Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Hydroxyapatite 830mg tablets 50 tablet | Is pack of | False | Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Hydroxyapatite 830mg tablets 50 tablet | Has VMP | True | Product containing precisely durapatite 830 milligram/1 each conventional release oral tablet (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR